1. Home
  2. NVCR vs PDO Comparison

NVCR vs PDO Comparison

Compare NVCR & PDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • PDO
  • Stock Information
  • Founded
  • NVCR 2000
  • PDO 2020
  • Country
  • NVCR Switzerland
  • PDO United States
  • Employees
  • NVCR N/A
  • PDO N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • PDO Trusts Except Educational Religious and Charitable
  • Sector
  • NVCR Health Care
  • PDO Finance
  • Exchange
  • NVCR Nasdaq
  • PDO Nasdaq
  • Market Cap
  • NVCR 1.9B
  • PDO 1.6B
  • IPO Year
  • NVCR 2015
  • PDO N/A
  • Fundamental
  • Price
  • NVCR $15.58
  • PDO $13.15
  • Analyst Decision
  • NVCR Buy
  • PDO
  • Analyst Count
  • NVCR 6
  • PDO 0
  • Target Price
  • NVCR $34.17
  • PDO N/A
  • AVG Volume (30 Days)
  • NVCR 736.7K
  • PDO 520.0K
  • Earning Date
  • NVCR 04-24-2025
  • PDO 01-01-0001
  • Dividend Yield
  • NVCR N/A
  • PDO 11.80%
  • EPS Growth
  • NVCR N/A
  • PDO N/A
  • EPS
  • NVCR N/A
  • PDO N/A
  • Revenue
  • NVCR $605,220,000.00
  • PDO N/A
  • Revenue This Year
  • NVCR $3.14
  • PDO N/A
  • Revenue Next Year
  • NVCR $10.63
  • PDO N/A
  • P/E Ratio
  • NVCR N/A
  • PDO N/A
  • Revenue Growth
  • NVCR 18.82
  • PDO N/A
  • 52 Week Low
  • NVCR $11.70
  • PDO $10.65
  • 52 Week High
  • NVCR $34.13
  • PDO $13.31
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 34.24
  • PDO 46.17
  • Support Level
  • NVCR $15.49
  • PDO $12.42
  • Resistance Level
  • NVCR $17.06
  • PDO $13.17
  • Average True Range (ATR)
  • NVCR 1.06
  • PDO 0.43
  • MACD
  • NVCR -0.01
  • PDO -0.00
  • Stochastic Oscillator
  • NVCR 20.42
  • PDO 62.91

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About PDO PIMCO Dynamic Income Opportunities Fund of Beneficial Interest

PIMCO Dynamic Income Opportunities Fund is a closed-end management investment company. The fund's primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities.

Share on Social Networks: